Literature DB >> 33826714

Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.

Antonio Dono1,2, Ankush Chandra1, Leomar Y Ballester1,2,3, Yoshua Esquenazi1,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33826714      PMCID： PMC8203418          DOI： 10.1093/neuros/nyab100

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  21 in total

Review 1.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 3.  A Practical Overview on the Molecular Biology of Meningioma.

Authors:  Pedro David Delgado-López; Esther Cubo-Delgado; Jerónimo Javier González-Bernal; Javier Martín-Alonso
Journal:  Curr Neurol Neurosci Rep       Date:  2020-11-02       Impact factor: 5.081

4.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.

Authors:  M H Ruttledge; J Sarrazin; S Rangaratnam; C M Phelan; E Twist; P Merel; O Delattre; G Thomas; M Nordenskjöld; V P Collins
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

5.  Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.

Authors:  Dorothee Cäcilia Spille; Katharina Heß; Cristina Sauerland; Nader Sanai; Walter Stummer; Werner Paulus; Benjamin Brokinkel
Journal:  World Neurosurg       Date:  2016-06-22       Impact factor: 2.104

Review 6.  Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.

Authors:  Christian Mirian; Anne Katrine Duun-Henriksen; Tareq Juratli; Felix Sahm; Sabine Spiegl-Kreinecker; Matthieu Peyre; Annamaria Biczok; Jörg-Christian Tonn; Stéphane Goutagny; Luca Bertero; Andrea Daniela Maier; Maria Møller Pedersen; Ian Law; Helle Broholm; Daniel P Cahill; Priscilla Brastianos; Lars Poulsgaard; Kåre Fugleholm; Morten Ziebell; Tina Munch; Tiit Mathiesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-02-10       Impact factor: 10.154

7.  Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Authors:  Annamaria Biczok; Christine Jungk; Rupert Egensperger; Andreas von Deimling; Bogdana Suchorska; Joerg C Tonn; Christel Herold-Mende; Christian Schichor
Journal:  J Neurooncol       Date:  2019-11-11       Impact factor: 4.130

8.  TERT Promoter Mutations and Risk of Recurrence in Meningioma.

Authors:  Felix Sahm; Daniel Schrimpf; Adriana Olar; Christian Koelsche; David Reuss; Juliane Bissel; Annekathrin Kratz; David Capper; Sebastian Schefzyk; Thomas Hielscher; Qianghu Wang; Erik P Sulman; Sebastian Adeberg; Arend Koch; Ali Fuat Okuducu; Stefanie Brehmer; Jens Schittenhelm; Albert Becker; Benjamin Brokinkel; Melissa Schmidt; Theresa Ull; Konstantinos Gousias; Almuth Friederike Kessler; Katrin Lamszus; Jürgen Debus; Christian Mawrin; Yoo-Jin Kim; Matthias Simon; Ralf Ketter; Werner Paulus; Kenneth D Aldape; Christel Herold-Mende; Andreas von Deimling
Journal:  J Natl Cancer Inst       Date:  2015-12-13       Impact factor: 13.506

9.  H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.

Authors:  Felix Behling; Christina Fodi; Irina Gepfner-Tuma; Kristina Kaltenbach; Mirjam Renovanz; Frank Paulsen; Marco Skardelly; Jürgen Honegger; Marcos Tatagiba; Jens Schittenhelm; Ghazaleh Tabatabai
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

10.  Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Authors:  Priscilla K Brastianos; Peleg M Horowitz; Sandro Santagata; Robert T Jones; Aaron McKenna; Gad Getz; Keith L Ligon; Emanuele Palescandolo; Paul Van Hummelen; Matthew D Ducar; Alina Raza; Ashwini Sunkavalli; Laura E Macconaill; Anat O Stemmer-Rachamimov; David N Louis; William C Hahn; Ian F Dunn; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.